Inventor

Tamar Tchkonia

Inventor

Rochester, MN, US

Overview

16→

Patents

2017–2019

Patent span

Human necessities

Primary field (CPC A)

Patents· 16 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes25%

C12NMicroorganisms or enzymes25%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms21%

A01KAnimal husbandry3%

C07KPeptides3%

PatentTitleYear

10,517,866Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor2019 10,478,432Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye2019 10,478,433Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss2019 10,413,542Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase2019 10,328,073Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells2019 10,328,058Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques2019 10,258,618Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen2019 10,251,376Increasing healthy lifespan and delaying progression of age-related phenotypes by selectively removing senescent cells2019 10,213,426Method of optimizing conditions for selectively removing a plurality of senescent cells from a tissue or a mixed cell population2019 10,130,628Treatment of joint pain2018 10,010,546Treatment of ophthalmic conditions by selectively removing senescent cells from the eye2018 9,993,472Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM22018 9,980,962Use of sulfonamide inhibitors of Bcl-2 to treat senescence-associated lung conditions such as pulmonary fibrosis and chronic obstructive pulmonary disease2018 9,968,076Transgenic animals capable of being induced to delete senescent cells2018 9,855,266'Treatment for osteoarthritis by intra-articular administration of a cis-imidazoline'2018 9,849,128Unit dose of a cis-imidazoline for treating an osteoarthritic joint by removing senescent cells2017

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2017–2019Patents assigned to MAYO FOUND MEDICAL EDUCATION & RES (16)· patent assignee history

2017–2019Patents assigned to BUCK INST RES AGING (14)· patent assignee history

2017–2019Patents assigned to UNITY BIOTECHNOLOGY INC (14)· patent assignee history

2017–2018Patents assigned to UNIV JOHNS HOPKINS (4)· patent assignee history

2017–2019Based in Rochester, MN, US· patent location history

2019Patents assigned to BUCK INSTITUE FOR RES ON AGING (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
MAYO FOUND MEDICAL EDUCATION & RES	16	2017–2019
BUCK INST RES AGING	14	2017–2019
UNITY BIOTECHNOLOGY INC	14	2017–2019
UNIV JOHNS HOPKINS	4	2017–2018
BUCK INSTITUE FOR RES ON AGING	1	2019

Locations

Location	Patents	Span
Rochester, Minnesota, US	16	2017–2019